Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

3325008 Title: COMPOSITIONS IMMUNOGÈNES CONTENANT DES ANTIGÈNES SACCHARIDIQUES CAPSULAIRES CONJUGUÉS, KITS COMPRENANT CES COMPOSITIONS ET LEURS UTILISATIONS

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
167416957
WO application number:
IB2016054217
Type:
European patent granted for BE
Status:
Open
Publication number:
3325008
WO publication number:
WO2017013548
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
18/07/2016
Grant date:
10/09/2025
EP publication date:
30/05/2018
WO publication date:
26/01/2017
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
10/09/2025
EP B1 publication date:
10/09/2025
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
18/07/2036

Applicant

Name:
Pfizer Inc.
Legal Form:
From:
10/09/2025
Address:
66 Hudson Boulevard East, New York, NY 10001-2192, United States (US)
To:

Inventor

1

Name:
WATSON, Wendy Jo
Legal Form:
Address:
Blue Bell, Pennsylvania 19422, United States (US)

2

Name:
JODAR MARTIN-MONTALVO, Luis Pascual
Legal Form:
Address:
Villanova, Pennsylvania 19085, United States (US)

3

Name:
ISTURIZ, Raul Enrique
Legal Form:
Address:
Norristown, Pennsylvania 19403, United States (US)

4

Name:
REINERT, Ralf Rene
Legal Form:
Address:
65812 Bad Soden im Taunus, Germany (DE)

Priority

Priority patent number:
201562194965 P
Priority date:
21/07/2015
Priority country:
United States (US)

Classification

IPC or IDT classification:
A61K 39/09; A61K 39/385; A61K 39/00;

Publication

European Patent Bulletin

1

Issue number:
202537
Publication date:
10/09/2025
Description:
Grant (B1)

2

Issue number:
202540
Publication date:
01/10/2025
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual fee

Annual fee(s) Due Date:
31/07/2026
Annual fee number:
11
Annual fee amount:
215 Euro
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type